DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Incyte Corporation (INCY)
« Back to company indexINCY Chatter Timeline
Stock Ticker for INCY
Most Active Tweeters for INCY
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @ChartMill | 4 |
| @semodough | 3 |
| @TickerReport | 3 |
| @AlertTrade | 2 |
Recent Tweets for INCY
 |
@LargeVoidBot Daily Reversal (10:07): $INCY Last: 78.41; pHigh: 78.17; rVol: 0.815; pClose: 76.43; LOD: 75.6300; Perf: 2.6% 10:09am |
 |
@commander_x09 RT @semodough: $INCY catalysts Results of REACH-2 & REACH 3 ph.III studies for full approval in acute GVHD & filing in chronic GVHD (2H19).… 9:09am |
 |
@semodough $INCY catalysts Results of REACH-2 & REACH 3 ph.III studies for full approval in acute GVHD & filing in chronic GVH… https://t.co/7G0ciOkZwi 9:09am |
|
@commander_x09 RT @semodough: RBC $INCY See Balanced Setup into 2H19 GvHD Catalysts, with Higher-Impact Events Potentially in 2020-number of key catalysts… 9:09am |
|
@semodough RBC $INCY See Balanced Setup into 2H19 GvHD Catalysts, with Higher-Impact Events Potentially in 2020-number of key… https://t.co/eBBDRDNTCo 9:09am |
 |
@Tickeron $INCY in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on January 24, 2019. View odds for thi… https://t.co/JwAzaPW7S6 8:09am |
 |
@stocknewstimes Incyte $INCY Research Coverage Started at BMO Capital Markets https://t.co/8fl7lCupeM 6:09am |
|
@Tickeron $INCY in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on January 24, 2019. View odds for thi… https://t.co/ssU0MVmrjZ September 15th 2019, 9:09pm |
 |
@TickerReport BMO Capital Markets Begins Coverage on Incyte $INCY https://t.co/pRhLRHduse September 15th 2019, 2:09pm |
 |
@TranscriptDaily BMO Capital Markets Begins Coverage on Incyte $INCY https://t.co/HS3E6NOuNp September 15th 2019, 2:09pm |
 |
@Gambiste1 RT @bs_marker: We're still looking for someone else who can beat our performances! Help us find them! RT please. $INCY Last close: 2019-09… September 15th 2019, 9:09am |
 |
@bs_marker The first informative #App on Pivot Points. Stock: $INCY Last close: 2019-09-13 ($ 76.430) PIVOT POINT ------------… https://t.co/O0184XqpHN September 15th 2019, 8:09am |
|
@bs_marker We're still looking for someone else who can beat our performances! Help us find them! RT please. $INCY Last close… https://t.co/bQ6IpdiYUO September 15th 2019, 8:09am |
 |
@ChartMill $INCY has a Quick Ratio of 5.59, indicating it is financially healthy. https://t.co/yiNP1tdKpY https://t.co/V39uPSctMr September 15th 2019, 3:09am |
 |
@MarketChmln $INCY upcoming event September 18: Bank of America Merrill Lynch Global Healthcare Conference. Options expiring on… https://t.co/1JK4wYqQXP September 14th 2019, 9:09pm |
 |
@ThisLincolnian BMO Capital Markets Begins Coverage on Incyte $INCY https://t.co/PSfrKvYERJ September 13th 2019, 7:09pm |
 |
@WeekHerald Incyte $INCY Receives New Coverage from Analysts at BMO Capital Markets https://t.co/Fplb85o5tJ September 13th 2019, 7:09pm |
 |
@tradnews_ RT @AlertTrade: UP/DOWNGRADES ? $INCY: BMO Capital Markets starts at Market Perform https://t.co/wPmH29Hpto via ? https://t.co/VS8RO1bzXJ September 13th 2019, 2:09pm |
 |
@AlertTrade UP/DOWNGRADES ? $INCY: BMO Capital Markets starts at Market Perform https://t.co/wPmH29Hpto via ? https://t.co/VS8RO1bzXJ September 13th 2019, 2:09pm |
 |
@Briefingcom $INCY: BMO Capital Markets starts at Market Perform September 13th 2019, 2:09pm |
 |
@ActionTrading1 $INCY 4 Hours https://t.co/Vn1EffNBnW September 13th 2019, 2:09pm |
|
@Tickeron $INCY in Uptrend: 50-day Moving Average broke above 200-day Moving Average on January 24, 2019. View odds for this… https://t.co/dLUapRVYOQ September 13th 2019, 11:09am |
|
@ActionTrading1 $INCY 4 Hours https://t.co/Fxk2Po0VBp September 13th 2019, 8:09am |
 |
@1MinuteStock Recommendation #HOLD for $INCY with UB rating - 2.8 out of 5. https://t.co/dzBZTQNhOr September 12th 2019, 11:09pm |
|
@1MinuteStock Recommendation #HOLD for $INCY with UB rating - 2.7 out of 5. https://t.co/dzBZTQNhOr September 12th 2019, 10:09pm |
 |
@tstamm7002 $INCY getting whooped again September 12th 2019, 12:09pm |
 |
@Miljenkoz Is there any other analyst with rating *upgrade*? $INCY September 12th 2019, 12:09pm |
|
@Tickeron $INCY in Uptrend: 50-day Moving Average broke above 200-day Moving Average on January 24, 2019. View odds for this… https://t.co/Gdo9huB6Td September 12th 2019, 9:09am |
 |
@AmericanBanking BMO Capital Markets Begins Coverage on Incyte $INCY https://t.co/oleqUznaSN #stocks September 12th 2019, 8:09am |
|
@AmericanBanking Incyte Co. $INCY Receives Consensus Rating of “Buy” from Brokerages https://t.co/RIvDIls2ov #stocks September 12th 2019, 6:09am |
|
@AlertTrade UP/DOWNGRADES ? $INCY: BMO Capital Markets starts at Market Perform https://t.co/1i4twPLfb4 via ? https://t.co/VS8RO1bzXJ September 11th 2019, 7:09pm |
 |
@confcalltran Incyte Corporation's EVP %26 General Counsel just picked up 76 shares https://t.co/HLzsPC56Zf $INCY September 11th 2019, 4:09pm |
 |
@InsiderAlertsIA $INCY: New Insider Filing on EVP & General Counsel MARIA E PASQUALE: https://t.co/Cb5mn432co September 11th 2019, 4:09pm |
|
@Tickeron $INCY in Uptrend: 50-day Moving Average broke above 200-day Moving Average on January 24, 2019. View odds for this… https://t.co/8bpr2DgVRa September 11th 2019, 9:09am |
 |
@edtaussig RT @semodough: $CALA and partner $INCY are scheduled to present INCB001158 (CB-1158 [arginase inhibitor]) Phase I clinical data in an oral… September 11th 2019, 3:09am |
|
@TickerReport Incyte Co. $INCY to Post Q3 2019 Earnings of $0.45 Per Share, Oppenheimer Forecasts https://t.co/A5pka3BpfF September 11th 2019, 1:09am |
 |
@WatchlistN $540.90 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/FpVdKXQeia September 10th 2019, 10:09pm |
 |
@ConsumerFeed Analysts Anticipate Incyte Co. $INCY Will Post Earnings of $0.65 Per Share https://t.co/PhyDHyb85G September 10th 2019, 10:09pm |
|
@semodough $CALA and partner $INCY are scheduled to present INCB001158 (CB-1158 [arginase inhibitor]) Phase I clinical data in… https://t.co/AwQNlmOc09 September 10th 2019, 9:09pm |
 |
@Ogut_Ozgur fwiw $incy putting strong emphasis on the importance of the itacitinib gvhd reading for the company, and again stre… https://t.co/GX57F28GXS September 10th 2019, 8:09pm |
|
@ChartMill $INCY is growing strongly and shows a nice technical setup now! https://t.co/1qZp7ZnJqT September 10th 2019, 6:09pm |
|
@Miljenkoz $INCY Did someone recently upgraded INCY? September 10th 2019, 3:09pm |
|
@Tickeron $INCY in Uptrend: 50-day Moving Average broke above 200-day Moving Average on January 24, 2019. View odds for this… https://t.co/VY0TBecVsI September 10th 2019, 9:09am |
|
@TickerReport Incyte $INCY Cut to “Sell” at ValuEngine https://t.co/kutYdjjeaA September 10th 2019, 5:09am |
|
@ChartMill Our 'Technical Setups in Strongly Growing Stocks' lists $INCY today! https://t.co/1qZp7ZnJqT September 10th 2019, 4:09am |
|
@ChartMill A very nice breakout setup pattern for $INCY, will it break out? https://t.co/1qZp7ZnJqT September 9th 2019, 9:09pm |
|
@Tickeron $INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on September 4, 2019. View odds for t… https://t.co/MvigxETFf3 September 9th 2019, 9:09am |
|
@Tickeron $INCY in Uptrend: 50-day Moving Average moved above 200-day Moving Average on January 24, 2019. View odds for this… https://t.co/YPVp7Xo4NO August 11th 2019, 7:08am |
|
@AlertTrade RT @SwingTradeBot: Recent $INCY technical alerts: Crossed Above 20 DMA plus 13 more alerts... https://t.co/w5vDMJe2Lv August 10th 2019, 4:08pm |
 |
@SwingTradeBot Recent $INCY technical alerts: Crossed Above 20 DMA plus 13 more alerts... https://t.co/w5vDMJe2Lv August 10th 2019, 3:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.